<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335880">
  <stage>Registered</stage>
  <submitdate>23/08/2010</submitdate>
  <approvaldate>25/08/2010</approvaldate>
  <actrnumber>ACTRN12610000702011</actrnumber>
  <trial_identification>
    <studytitle>A trial of screening strategies for Cervical cancer prevention in Vanuatu</studytitle>
    <scientifictitle>A comparative study of three screening strategies for determining cervical cancer risk amongst 30-50 year old Vanuatu women</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CICR-0602
The University of Queensland Centre for Immunology and Cancer Research</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cervical cancer screening in healthy women</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Cervical (cervix)</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Epidemiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Screening interventions - each done to each trial subject  on one occasion only.
1) Visual Inspection of the cervix after application o f Acetic Acid (VIA) and after application of  Lugol's Iodine (VILI), 
2) Cervical Cytology  on a Papanicolau smear sample , 
3) Human Papillomavirus testing (Performed on the Papanicolau  smear sample) 
Cervical  Biopsy is the reference standard - taken from all subjects with any abnormality on any test, and on 10% of subjects with all tests normal.</interventions>
    <comparator>The comparator is a  Cervical Biopsy</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Early detection / Screening</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>detection of Biopsy proven cervical Intraepithelial Neoplasia (CIN)  2/3</outcome>
      <timepoint>Within one month of presentation for screening</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Relative efficacy of screening tests as assessed by their positive predicitve value, and negative predictive value, for biopsy proven CIN 2/3</outcome>
      <timepoint>On completion of data collection (12 months after study completion)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Asymptomatic Ni-Vanuatu women</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>50</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>past gynaecological surgery</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/04/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>1000</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Vanuatu</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The University of Queensland</primarysponsorname>
    <primarysponsoraddress>St Lucia 
Queensland
4072</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Australians Working Abroad</fundingname>
      <fundingaddress>c/o Dr Margaret McAdam
Adelaide St
Brisbane 
Queensland 4000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To assess the relative effectiveness of three possible means of early detection of cervical cancer risk in a population of healthy women in vanuatu.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The University of Queensland Human Ethics Experimentation Committee</ethicname>
      <ethicaddress>The University of Queensland
St Lucia 
Queensland 4072</ethicaddress>
      <ethicapprovaldate>1/02/2006</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ian Frazer</name>
      <address>University of Queensland Diamantina Institute
Princess Alexandra Hospital
Woolloongabba 4102 
Queensland</address>
      <phone>+61 7 32405315</phone>
      <fax />
      <email>i.frazer@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ian Frazer</name>
      <address>University of Queensland Diamantina Institute
Princess Alexandra Hospital
Woolloongabba 4102 
Queensland</address>
      <phone>+61 7 32405315</phone>
      <fax />
      <email>i.frazer@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ian Frazer</name>
      <address>University of Queensland Diamantina Institute
Princess Alexandra Hospital
Woolloongabba 4102 
Queensland</address>
      <phone>+61 7 3240 5315</phone>
      <fax />
      <email>i.frazer@uq.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>